Aethlon Medical, Inc.
General ticker "AEMD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.3M (TTM average)
Aethlon Medical, Inc. does not follow the US Stock Market performance with the rate: -39.0%.
Estimated limits based on current volatility of 10.6%: low 2.05$, high 2.54$
Factors to consider:
- Total employees count: 15 as of 2023
- Top business risk factors: Economic downturns and volatility, Geopolitical risks, Regulatory and compliance, Product liability, Supply chain disruptions
- Current price 68.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [16.33$, 63.25$]
- 2026-03-31 to 2027-03-31 estimated range: [6.67$, 29.59$]
Financial Metrics affecting the AEMD estimates:
- Negative: with PPE of -4.1 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Positive: Interest expense per share per price, % of 0.20 <= 0.73
Short-term AEMD quotes
Long-term AEMD plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $0.57MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.47MM | $12.64MM | $9.34MM |
| Operating Income | $-11.90MM | $-12.64MM | $-9.34MM |
| Non-Operating Income | $-0.13MM | $0.43MM | $-4.05MM |
| Interest Expense | $0.00MM | $0.00MM | $0.01MM |
| Income(Loss) | $-12.03MM | $-12.21MM | $-13.39MM |
| Net Income(Loss)* | $-12.03MM | $-12.21MM | $-13.39MM |
| Stockholders Equity | $15.06MM | $5.77MM | $5.12MM |
| Assets | $17.51MM | $8.25MM | $7.36MM |
| Operating Cash Flow | $-10.51MM | $-10.13MM | $-7.65MM |
| Capital expenditure | $0.94MM | $0.25MM | $0.00MM |
| Investing Cash Flow | $-0.94MM | $-0.25MM | $0.00MM |
| Financing Cash Flow | $8.91MM | $1.29MM | $7.73MM |
| Earnings Per Share** | $-58.57 | $-48.58 | $-85.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.